Potential Lawsuit: Ozempic and Mounjaro Weight Loss Lawsuit News and Legal Information

Ozempic lawsuits allege Novo Nordisk failed to warn consumers that its diabetes and weight loss drug carries dangerous side effects, including severe gastroparesis (known as stomach paralysis), gastroenteritis, gallbladder disease and other serious health issues. Eli Lilly’s weight loss drug Mounjaro—and Ozempic’s competitor– is also accused of failure to warn of severe gastrointestinal side effects. The first lawsuit filed in August 2023 follows an investigative report by CNN the previous month, which highlighted a number of Ozempic and Wegovy (another Novo weight loss drug) users suffering from stomach paralysis along with evidence that the diet drug manufacturers knew of the potential risk.